Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors

Current Topics in Medicinal Chemistry

Volumn 5, Issue 1, 2005, Pages 43-58

  McGaraughty, Steve ^a   Cowart, Marlon ^a   Jarvis, Michael F ^a   Berman, Robert F ^b  

^a ABBOTT LABORATORIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4,5 DIMETHYL 3 (3 TRIFLUOROMETHYLBENZOYL)THIOPHENE; 2 CHLORO 6 N CYCLOPENTYLADENOSINE; 2 CHLOROADENOSINE; 5 IODOTUBERCIDIN; 5' AMINO 5' DEOXYADENOSINE; 8 (4 SULFOPHENYL)THEOPHYLLINE; A 134974; A 286501; ABT 501; ABT 702; ADENOSINE; ADENOSINE A2 RECEPTOR; ADENOSINE KINASE; ADENOSINE KINASE INHIBITOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; AMINOPHYLLINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLITOCINE; CYCLOHEXYLADENOSINE; DIAZEPAM; GP 790; GP 947; PHENOBARBITAL; PHENYTOIN; PYRROLIDINE DERIVATIVE; THEOPHYLLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID;

ANTICONVULSANT ACTIVITY; ANTINOCICEPTION; BRAIN HEMORRHAGE; CENTRAL NERVOUS SYSTEM; DISEASE CONTROL; DISEASE MODEL; DRUG EFFICACY; DRUG MECHANISM; DRUG SPECIFICITY; DRUG STRUCTURE; EPILEPSY; HEART DISEASE; HUMAN; MOUSE; NEUROMODULATION; NONHUMAN; PAIN; PERIPHERAL NERVOUS SYSTEM; RAT; REVIEW; SEIZURE; STRUCTURE ACTIVITY RELATION;

ADENOSINE KINASE; ANALGESICS; ANIMALS; ANTICONVULSANTS; ENZYME INHIBITORS; EPILEPSY; HUMANS; PAIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 13444273445     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026053386845     Document Type: Review

References (145)

1. Burnstock, G. Purinergic Nerves. Pharmacol. Rev. 1972, 24, 509-581.
2. Ralevic, V.; Burnstock, G. Receptors for Purines and Pyrimidines. Pharmacol. Rev. 1998, 50, 413-492.
3. North, R.A. Molecular Physiology of P2X Receptors. Physiol Rev. 2002, 82, 1013-1067.
4. Jacobson, K.A.; Jarvis, M.F.; Williams, M. Purine and Pyrimidine (P2) Receptors as Drug Targets. J. Med. Chem. 2002 45, 4057-4093.
5. McGaraughty, S.; Cowart, M.; Jarvis, M.F. Recent Developments in the Discovery of Novel ADO Kinase Inhibitors: Mechanism of Action and Therapeutic Potential. CNS Drug Rev. 2001, 7, 415-432.
6. Masino, S.A.; Dunwiddie, T.V. A Transient Increase in Temperature Induces Persistent Potentiation of Synaptic Transmission in Rat Hippocampal Slices. Neuroscience 2000, 101, 907-912.
7. Newby, A.C. Adenosine and the Concept of "Retaliatory Metabolites". Trends Biochem Sci. 1984, 2, 42-44.
8. Moser, G.H.; Schrader, J.; Duessen, A. Turnover of Adenosine in Plasma of Human and Dog Blood. Am. J. Physiol. 1989, 25 C799-C806.
9. Arch, J.R.S.; Newsholme, E.A. The Control of the Metabolism and the Hormonal Role of Adenosine. Essays Biochem. 1978, 14, 82-123.
10. Mullane, K.; Young, M. Acadesine: Prototype ADO Regulating Agent for Treating Myocardial Ischemia-Reperfusion Injury. Drug Dev. Res. 1993, 23, 336-343.
11. Kowaluk, E.A.; Jarvis, M.F. Therapeutic Potential of Adenosine Kinase Inhibitors. Expert. Opin. Investig. Drugs 2000 9, 551-564.
12. McNally, T.; Helfrich, R.J.; Cowart, M.; Dorwin, S.A.; Meuth, J.L.; Idler, K.B.; Klute, K.A.; Simmer, R.L.; Kowaluk. E.A.; Halbert, D.N.; Cloning and Expression of the Adenosine Kinase Gene From Rat and Human Tissues. Biochem. Biophys. Res. Comm. 1997, 231, 645-650.
13. Spychala, J.; Datta, N.S.; Takabayashi, K.; Datta, M.; Fox, I.H.; Gribbin, T.; Mitchell, B.S. Cloning of Human Adenosine Kinase cDNA: Sequence Similarity to Microbial Ribokinases and Fructokinases. Proc. Natl. Acad. Sci. USA 1996, 93, 1232-1237.
14. Matthews, I.L.; Erion, M.D.; Ealick. S.E. Structure of Human Adenosine Kinase at 1.5a Resolution. Biochemistry 1998, 10 15607-15620.
15. Hawkins, C.F.; Bagnara, A.S. Adenosine Kinase from Human Erthrocytes: Kinetic Studies and Characterization of Adenosine Binding Sites. Biochemistry 1987, 26, 1982-1987.
16. Lin, B.B.; Hurley, M.C.; Fox, I.H. Regulation of Adenosine Kinase by Adenosine Analogs. Mol. Pharmacol. 1988, 34, 501-505.
17. Davies, L. P.; Jamieson, D. D.; Baird-Lambert, J. A.; Kazlauskas, R. Halogenated Pyrrolopyrimidine Analogs of ADO from Marine Organisms: Pharmacological Activities and Potent Inhibition of ADO Kinase. Biochem. Pharm. 1984, 33, 347-355.
18. Newby, A.C.; Holmquist, A.C.; Illingworth, J.; Pearson, J.D. The Control of Adenosine Concentration in Polymorphonuclear Leukocytes, Cultured Cells and Isolated Perfused Heart from the Rat. Biochem. J. 1983, 214, 317-323.
19. Engler, R.L. Consequences of Activation and ADO Mediated Inhibition of Granulocytes During Myocardial Ischemia. Fed. Proc. 1987, 46, 2407-2412.
20. Britton, D.R.; Mikusa, J.; Lee, C-H.; Jarvis, M.F.; Williams, M.; Kowaluk, E.A. Site and Event Specific Increase of Striatal Adenosine Release by Adenosine Kinase Inhibition in Rats. Neurosci. Lett. 1999, 266, 93-96.
21. Pak, M.A.; Haas, H.L.; Decking, U.K.M.; Schrader, J. Inhibition of Adenosine Kinase Increases Endogenous Adenosine and Depresses Neuronal Activity in Hippocampal Slices. Neuropharmacology 1994, 33, 1049-1053.
22. Golembiowska, K.; White. T.D.; Sawynok, J. Adenosine Kinase Inhibitors Augment Release of Adenosine from Spinal Cord Slices. Eur. J. Pharmacol. 1996, 307, 157-162.
23. Liu, X.J.; White, T.D.; Sawynok, J. Potentiation of Formalin-Evoked Adenosine Release by an Adenosine Kinase Inhibitor and an Adenosine Deaminase Inhibitor in the Rat Hind Paw: a Microdialysis Study. Eur. J. Pharmacol. 2000, 408, 143-152.
24. Firestein, G.S. Anti-Inflammatory Effects of Adenosine Kinase Inhibitors in Acute and Chronic Inflammation. Drug Dev. Res. 1996, 39, 371-376.
25. Wang, B.; Tang, J.; White, P.F.; Foster, A.C.; Grettenberger, H.M.; Kopcho, J.; Wender, R.H. The Effect of GP683, an ADO Kinase Inhibitor, on the Desflurane Anesthetic Requirement in Dogs. Anesth. Analges. 1997, 85, 675-680.
26. Fukunaga, A.F.; Alexander, G.E.; Stark, CW. Characterization of the Analgesic Actions of Adenosine: Comparison of Adenosine and Remifentanil Infusions in Patients Undergoing Major Surgical Procedures. Pain 2003, 101, 129-138.
27. Lee, C. H.; Jiang, M.; Cowart, M.; Gfesser, G.; Perner, R.; Kim, K. H.; Gu, Y. G.; Williams, M.; Jarvis, M. F.; Kowaluk, E. A.; Stewart, A. O.; Bhagwat, S. S. Discovery of 4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl pyrido[2,3-d pyrimidine, an Orally Active, Non-Nucleoside ADO Kinase Inhibitor. J. Med. Chem. 2001, 44, 2133-2138.
28. Erion, M.D.; Wiesner, J.B.; Dare, J.; Kopcho, J.; Ugarkar, B.G. Design, Synthesis and Anticonvulsant Activity of the Potent ADO Kinase Inhibitor GP-3269. Nucleosides Nucleotides 1997, 16 1013-1021.
29. Ugarkar, B. G.; DaRe, J. M.; Kopcho, J. J.; Browne, C. E. III; Schanzer, J. M.; Wiesner, J. B.; Erion, M. D. ADO Kinase Inhibitors. 1. Synthesis, Enzyme Inhibition, and Antiseizure Activity of 5-Iodotubercidin Analogues. J. Med. Chem. 2000, 43, 2883-2893.
30. Ugarkar, B. G.; Castellino, A. J.; DaRe, J. M.; Kopcho, J. J.; Schanzer, J. M.; Wiesner, J. B.; Erion, M. D. ADO Kinase Inhibitors. 2. Synthesis, Enzyme Inhibition, and Antiseizure Activity of Diaryltubercidin Analogues. J. Med. Chem. 2000, 43, 2894-2905.
31. Jarvis, M.F.; Yu, H.; Kohlhaas, K.; Alexander, K.; Lee, C-H.; Jiang, M.; Bhagwat, S.S.; Williams, M.; Kowaluk, E.A. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl pyrido[2,3-d]pyrimidine), a Novel Orally Effective ADO Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties: I. In vitro Characterization and Acute Antinociceptive Effects in the Mouse. J. Pharmacol. Exp. Ther. 2000, 295, 1156-1164.
32. Kowaluk, E.A.; Mikusa, J.; Wismer, C.T.; Zhu, C.Z.; Schweitzer, E.; Lynch, J.J.; Lee, C-H.; Jiang, M.; Bhagwat, S.S.; Gomtsyan, A.; McKie, J.; Cox, B.F.; Polakowski, J.; Reinhart, G.; Williams, M.; Jarvis, M.F. ABT-702, a Novel Orally Effective ADO Kinase (AK) Inhibitor Analgesic with Anti-Inflammatory Properties. II. Antinociceptive and Anti-Inflammatory Effects in Rat Models of Persistent, Inflammatory, and Neuropathic Pain. J Pharmacol. Exp. Ther. 2000, 295, 1165-1174.
33. Wiesner, J.B.; Ugarkar, B.G.; Castellino, A.J.; Barankiewicz, J.; Dumas, D.P.; Gruber, H.E.; Foster, A.C.; Erion, M.D. ADO Kinase Inhibitors as a Novel Approach to Anti-Convulsant Therapy. J. Pharmacol. Exp. Ther. 1999, 289, 1669-1677.
34. Kazlauskas, R.; Murphy, P. T.; Wells, R. J.; Baird-Lambert, J. A.; Jamieson, D. D. Australian J. Chem. 1983, 36, 165-170.
35. Kowaluk, E.A.; Kohlhaas, K.; Bannon, A.; Gunther K.; Lynch, J.J.; Jarvis, M.F. Characterization of the Effects of ADO Kinase Inhibitors on Acute Thermal Nociception in Mice. Pharmacol. Biochem. Behav. 1999, 63, 83-91.
36. Jarvis, M. F.; Mikusa, J.; Chu, K. L.; Wismer, C. T.; Honore, P.; Kowaluk, E. A.; McGaraughty, S. Comparison of the Ability of ADO Kinase Inhibitors and ADO Receptor Agonists to Attenuate Thermal Hyperalgesia and Reduce Motor Performance in Rats. Pharm., Biochem. Behav. 2002, 73, 573-581.
37. Ugarkar, B. G.; Castellino, A. J.; DaRe, Ramirez-Weinhouse, M.; J. M.; Kopcho, J. J.; Rosengren, S.; Erion, M. D. ADO Kinase Inhibitors. 3. Synthesis, SAR, and Antiinflammatory Activity of a Series of L-lyxofuranosyl Nucleosides. J. Med. Chem. 2003, 46, 4750-4760.
38. Bhagwat, S. S; Cowart, M. D. Heterocyclic Substituted Cyclopentane Compounds. WO 9640686 (Dec. 19, 1996).
39. Cowart, M.; Bennett, M. J.; Gfesser, G.; Bhagwat, S. S.; Kohlhaas, K. L.; Alexander, K. M.; Zhu, C.; Britton, D.; Lynch, H.; Yu, H.; Gunther, K.; Kerwin, J. F., Jr.; Kowaluk, E. A. SAR of a Series of Nucleoside Analogs as ADO Kinase Inhibitors. 213th Natl. Meeting Am. Chem. Soc. San Francisco, 1997. MEDI 173.
40. Jarvis, M. F.; Yu, H.; McGaraughty, S.; Wismer, C. T.; Mikusa, J.; Zhu, C.; Chu, K.; Kohlhaas, K.; Cowart, M.; Lee, C. H.; Stewart, A. O.; Cox, B. F.; Polakowski, J.; Kowaluk, E. A. Analgesic and Anti-Inflammatory Effects of A-286501, a Novel Orally Active ADO Kinase Inhibitor. Pain 2002, 96, 107-118.
41. Zheng, G. Z.; Lee, C. H.; Pratt, J. K.; Perner, R. J.; Jiang, M.; Gomtsyan, A.; Matulenko, M. A.; Mao, Y.; Koenig, J. R.; Kim, K. H.; Muchmore, S.; Yu, H.; Kohlhaas, K.; Alenxander, K. M.; McGaraughty, S.; Chu, K. L.; Wismer, C. T.; Mikusa, J.; Jarvis, M. F.; Marsh, K.; Kowaluk, E. A.; Bhagwat, S. S.; Stewart, A. O. Pyridopyrimidine Analogues as Novel ADO Kinase Inhibitors. Bioorg. Med. Chem. Lett. 2001, 11 2071-2074.
42. Zheng, G.Z.; Mao, Y.; Lee, C-H.; Pratt, J.K.;, Koenig, JR.; Perner, R.J.; Cowart, M.D.; Gfesser, G.A.; McGaraughty, S.; Chu, K.L.; Zhu, C.; Yu, H.; Kohlhaas, K.; Alexander, K.M.; Wismer, C.T.; Mikusa, J.; Jarvis, M.F.; Kowaluk, E.A.; Stewart, A.O.; ADO Kinase Inhibitors: Polar 7-Substitutent of Pyridopyrimidine Derivatives Improving Their Locomotor Selectivity. Bioorg. Med. Chem. Lett. 2003, 13, 3041-3044.
43. Cowart, M.; Lee, C.-H.; Gfesser, G. A.; Bayburt, E. K.; Bhagwat, S. S.; Stewart, A. O.; Yu, H.; Kohlhaas, K. L.; McGaraughty, S.; Wismer, C. T.; Mikusa, J.; Zhu, C.; Alexander, K. M.; Jarvis, M. F.; Kowaluk, E. A. Structure-Activity Studies of 5-Substituted Pyridopyrimidinesas ADO Kinase Inhibitors. Bioorg. Med. Chem. Lett. 2001, 11, 83-86.
44. Hajduk, P. J.; Gomtsyan, A.; Didomenico, S.; Cowart, M.; Bayburt, E. K.; Solomon, L.; Severin, J.; Smith, R.; Walter, K.; Holzman, T. F.; Stewart, A.; McGaraughty, Jarvis, M. F.; Kowaluk, E. A.; Fesik, S. W. Design of ADO Kinase Inhibitors from the NMR-Based Screening of Fragments. J. Med. Chem. 2000, 43, 4781-4786.
45. Gfesser, G. A.; Bayburt, E. K.; Cowart, M.; DiDomenico, S.; Gomtsyan, A.; Lee, C.-H.; Stewart, A. O.; Jarvis, M. F.; Kowaluk, E. A.; Bhagwat, S. S. Synthesis and Structure-Activity Relationships of 5-Heteroatomsubstituted Pyridopyrimidines as ADO Kinase Inhibitors. Eur. J. Med. Chem. 2003, 38, 245-252.
46. Perner, R. J.; Gu, Y.-G.; Lee, C.-H.; Bayburt, E. K.; McKie, J.; Alexander, K. M.; Kohlhaas, K. L.; Wismer, C. T.; Mikusa, J.; Jarvis, M. F.; Kowaluk, E. A.; Bhagwat, S. S. 5,6,7-Trisubstituted 4-Aminopyrido[2,3-d]pyrimidines as Novel Inhibitors of ADO Kinase. J. Med. Chem. 2003, 46, 5249-5257.
47. Gomtsyan, A.; DiDomenico, S.; Lee, C.-H.; Matulenko, M. A.: Kim, K.; Kowaluk, E. A.; Wismer, C. T.; Mikusa, J.; Yu, H.; Kohlhaas, K.; Jarvis, M. F.; Bhagwat, S. S. Design, Synthesis, and Structure-Activity Relationship of 6-Alkynylpyrimidines as Potent ADO Kinase Inhibitors. J. Med. Chem. 2002, 45, 3639-3648.
48. Lee, C.-H.; Daanen, J. F.; Jiang, M.; Yu, H.; Kohlhaas, K. L.; Alexander, K.; Jarvis, M. F.; Kowaluk, E. A.; Bhagwat, S. S. Synthesis and Biological Evaluation of Clitocine Analogues as ADO Kinase Inhibitors. Bioorg. Med. Chem. Lett. 2001, 11, 2419-2422.
49. Bischoff, E.; Hauswald, M.; Nell, P.; Rohrig, S.; Schlemmer, K.-H.; Steinhagen, H.; Stoltenfuss, J.; Weigand, S. German Patent Application DE 10141212 A1 (June 3, 2003).
50. Dragunow, M.; Goddard, G.V.; Laverty, R. Is Adenosine an Endogenous Anticonvulsant? Epilepsia 1985, 26, 480-487.
51. Berman, R.F.; Jarvis, M.F.; Lupica, C.R. Adenosine Involvement in Kindled Seizures. In: Kindling (Wada JA, ed), Plenum Publishing Co. 1990, pp 423-435.
52. Knutsen, L.J.S.; Murray, T.F. (eds). Adenosine and ATP in Epilepsy. New York: Wiley-Liss 1997.
53. Malva, J.O.; Silva, A.P.; Cunha, R.A. Presynaptic Modulation Controlling Neuronal Excitability and Epileptogenesis: role of Kainate, Adenosine and Neuropeptide Y Receptors. Neurochem. Res. 2003, 28, 1501-1515.
54. Brundege, J.M.; Dunwiddie, T.V. Role of Adenosine as a Modulator of Synaptic Sctivity in the Central Nervous System. Adv. Pharmacol. 1997, 39, 353-391.
55. Yamazaki, Y.; Collinson, A.R.; Truong, V.L.; Lowenstein, J.M. Regulation of Soluble 5′-Nucleotidase I from Rabbit Heart. Adv. Exp. Med. Biol. 1989, 253B, 107-111.
56. Lloyd, H.G.; Lindstrom, K.; Fredholm, B.B. Intracellular Formation and Release of Adenosine from Rat Hippocampal Slices Evoked by Electrical Stimulation or Energy Depletion. Neurochem. Int. 1993 23, 173-185.
57. Lloyd, H.G.; Fredholm, B.B. Involvement of Adenosine Deaminase and Adenosine Kinase in Regulating Extracellular Adenosine Concentration in Rat Hippocampal Slices. Neurochem. Int. 1995 26, 387-395.
58. Brundege, J.M.; Diao, L.; Proctor, W.R.; Dunwiddie, T.V. The Role of Cyclic AMP as a Precursor of Extracellular Adenosine in the Rat Hippocampus. Neuropharmacology 1997, 36, 1201-1210.
59. Ribeiro, J.A.; Sebastiao, A.M.; de Mendonca, A. Adenosine Receptors in the Nervous System: Pathophysiological Implications. Progress in Neurobiology 2003, 68, 377-392.
60. Dunwiddie, T.V. The Physiological Role of Adenosine in the Central Nervous System. Int. Rev. Neurobiol. 1985, 27, 63-139.
61. Phillis, J.W.; Wu, P.H. (eds) Roles of Adenosine and Adenine Nucleotides in the Central Nervous System. New York: Raven Press 1983
62. Masino, S.A.; Diao, L.; Illes, P.; Zahniser, N.R.; Larson, G.A.; Johansson, B.; Fredholm, B.B.; Dunwiddie, T.V. Modulation of Hippocampal Glutamatergic Transmission by ATP is Dependent on Adenosine A(1) Receptors. J. Pharmacol. Exp. Ther. 2002, 303, 356-363.
63. Wu, L.G.; Saggau, P. Adenosine Inhibits Evoked Synaptic Transmission Primarily by Reducing Presynaptic Calcium Influx in Area CA1 of Hippocampus. Neuron 1994, 12, 1139-1148.
64. Dunwiddie, T.V.; Fredholm, B.B. Adenosine A1 Receptors Inhibit Adenylate Cyclase Activity and Neurotransmitter Release and Hyperpolarize Pyramidal Neurons in Rat Hippocampus. J. Pharmacol. Exp. Ther. 1989, 249, 31-37.
65. Greene, R.W.; Haas, H.L. The Electrophysiology of Adenosine in the Mammalian Central Nervous System. Prog. Neurobiol. 1991 36, 329-341.
66. Takigawa, T.; Alzheimer, C. Phasic and Tonic Attenuation of EPSPs by Inward Rectifier K+ Channels in Rat Hippocampal Pyramidal Cells. J. Physiol. 2002, 539, 67-75.
67. Winn, H.R.; Welsh, J.E.; Berne, R.M.; Rubio, R. Changes in Brain Adenosine During Bicuculline-Induced Seizures: Effect of Altered Arterial Oxygen Tensions. Trans. Am. Neurol. Assoc. 1979, 104, 239-241.
68. Winn, H.R.; Welsh, J.E; Rubio, R.; Berne, R.M. Changes in Brain Adenosine During Bicuculline-Induced Seizures in Rats. Effects of hypoxia and altered systemic blood pressure. Circ. Res. 1980, 47, 568-577.
69. Schrader, J.; Wahl, M.; Kuschinsky, W.; Kreutzberg, G.W. Increase of Adenosine Content in Cerebral Cortex of the Cat During Bicuculline-Induced Seizure. Pflugers Arch. 1980, 387, 245-251.
70. Park, T.S.; Van Wylen, D.G.; Rubio, R.; Berne, R.M. Interstitial Fluid Adenosine and Sagittal Sinus Blood Flow During Bicuculline-Seizures in Newborn Piglets. J. Cereb. Blood Flow Metab. 1987, 7, 633-639.
71. During, M.J.; Spencer, D.D. Adenosine: a Potential Mediator of Seizure Arrest and Postictal Refractoriness. Ann. Neurol. 32 1992, 618-624,
72. Berman, R.F.; Fredholm, B.B.; Aden, U.; O'Connor, W.T. Evidence for Increased Dorsal Hippocampal Adenosine Release and Metabolism During Pharmacologically Induced Seizures in Rats. Brain. Res. 2000, 872, 44-53.
73. Kaku, T.; Jiang, M.H.; Hada, J.; Morimoto, K.; Hayashi, Y. Sodium Nitroprusside-Induced Seizures and Adenosine Release in Rat Hippocampus. Eur. J. Pharmacol. 2001, 413, 199-205.
74. Kleinsorge, R.J.; Jarvis, M.J.; Berman, R.F. Prolonged Refractory Period in Amygdala Kindled Rats Following Adenosine Receptor Upregulation. Drug Development Res. 1993, 29, 287-291.
75. Fisher, R.S.; Schachter, S.C. The Postictal State: A Neglected Entity in the Management of Epilepsy. Epilepsy Behav. 2000, 1, 52-59.
76. Lupica, C.R.; Berman, R.F.; Jarvis, M.F. Chronic Theophylline Treatment Increases Adenosine A1, but not A2, Receptor Binding in the Rat Brain: an Autoradiographic Study. Synapse 1991, 9, 95-102.
77. Lupica, C.R.; Jarvis, M.F.; Berman, R.F. Chronic Theophylline Treatment in Vivo Increases High Affinity Adenosine A1 Receptor Binding and Sensitivity to Exogenous Adenosine in the in Vitro Hippocampal Slice. Brain Res. 1991, 542, 55-62.
78. Szot, P.; Sanders, R.C.; Murray, T.F. Theophylline-Induced Upregulation of A1-Adenosine Receptors Associated with Reduced Sensitivity to Convulsants. Neuropharmacology 1987, 26, 1173-1180.
79. Sanders, R.C.; Murray, T.F. Temporal Relationship Between A1 Adenosine Receptor Upregulation and Alterations in Bicuculline Seizure Susceptibility in Rats. Neurosci. Lett. 1989, 101, 325-330.
80. Abbracchio, M.M.; Fogliatto, G.; Paoletti, A.M.; Rovati, G.E.; Cattabeni, F. Prolonged in Vitro Exposure of Rat Brain Slices to Adenosine Analogues: Selective Desensitization of Adenosine A1 but not A2 Receptors. Eur. J. Pharmacol. 1992, 227, 317-324.
81. Angelatou, F.; Pagonopoulou, O.; Kostopoulos, G. Alterations of A1 Adenosine Receptors in Different Mouse Brain Areas after Pentylentetrazol-Induced Seizures, but not in the Epileptic Mutant Mouse 'Tottering'. Brain. Res. 1990, 534, 251-256.
82. Pagonopoulou, O.; Angelatou, F.; Kostopoulos, G. Effect of Pentylenetetrazol-Induced Seizures on A1 Adenosine Receptor Regional Density in the Mouse Brain: A Quantitative Autoradiographic Study. Neuroscience 1993, 56, 711-716.
83. Wybenga, M.P.; Murphy, M.G.; Robertson, H.A. Rapid Changes in Cerebellar Adenosine Receptors Following Experimental Seizures. Eur. J. Pharmacol. 1981, 75, 79-80.
84. Daval, J.; Werck, M. Autoradiographic Changes in Brain Adenosine A1 Receptors and Their Coupling to G Proteins Following Seizures in the Developing Rat. Dev. Brain Res. 1991, 59 237-47.
85. Doriat, J.F.; Koziel, V.; Humbert, A.C.; Daval, JL. Medium- and Long-Term Alterations of Brain A1 and A2A Adenosine Receptor Characteristics Following Repeated Seizures in Developing Rats. Epilepsy Res. 1999, 35, 219-228.
86. Gleiter, C.H.; Deckert, J.; Nutt, D.J.; Marangos, P.J. Electroconvulsive Shock (ECS) and the Adenosine Neuromodulatory System: Effect of Single and Repeated ECS on the Adenosine A1 and A2 Receptors, Adenylate Cyclase, and the Adenosine Uptake Site. J. Neurochem. 1989, 52, 641-646.
87. Vanore, G.; Giraldez, L.; Rodriguez de Lores Arnaiz, G.; Girardi, E. Seizure Activity Produces Differential Changes in Adenosine A1 Receptors within Rat Hippocampus. Neurochem. Res. 2001, 26, 225-230.
88. Simonato, M.; Varani, K.; Muzzolini, A.; Bianchi, C.; Beani, L.; Borea, P.A. Adenosine A1 Receptors in the Rat Brain in the Kindling Model of Epilepsy. Eur. J. Pharmacol. 1994, 265, 121-124.
89. Ekonomou, A.; Angelatou, F.; Vergnes, M.; Kostopoulos, G. Lower Density of A1 Adenosine Receptors in Nucleus Reticularis Thalami in Rats with Genetic Absence Epilepsy. Neuroreport 1998, 9 2135-2140.
90. Angelatou, F.; Pagonopoulou, O.; Maraziotis, T.; Olivier, A.; Villemeure, J.G.; Avoli. M.; Kostopoulos., G. Upregulation of A1 Adenosine Receptors in Human Temporal Lobe Epilepsy: a Quantitative Autoradiographic Study. Neurosci. Lett. 1993, 163, 11-14.
91. Glass, M.; Fault, R.L.; Bullock, J.Y.; Jansen, K.; Mee, E.W.; Walker, E.B.; Synek, B.J.; Dragunow, M. Loss of A1 Adenosine Receptors in Human Temporal Lobe Epilepsy. Brain. Res. 1996, 710, 56-68.
92. Dunwiddie, T.V.; Worth, T. Sedative and Anticonvulsant Effects of Adenosine Analogs in Mouse and Rat. J. Pharmacol. Exp. Ther. 1982, 220, 70-76.
93. Franklin, P.H.; Zhang, G.; Tripp, E.D.; Murray, T.F. Adenosine A1 Receptor Activation Mediates Suppression of (-) Bicuculline Methiodide-Induced Seizures in Rat Prepiriform Cortex. J. Pharmacol. Exp. Ther. 1989, 251, 1229-1236.
94. Moraidis, L; Bingmann, D. Epileptogenic actions of xanthines in relation to their affinities for adenosine A1 receptors in CA3 neurons of hippocampal slices (guinea pig). Brain Res. 1994, 640 140-145.
95. Dragunow, M.; Goddard, G.V.; Adenosine Modulation of Amygdala Kindling. Exp. Neurol. 1984, 84, 654-665.
96. Albertson, T.E. Amygdala-Kindled Postictal Inhibition: Effect of Intertrial Intervals on Repeated Days. Exp. Neurol. 1986, 92, 197-206.
97. Whitcomb, K.; Lupica, C.R.; Rosen, J.B.; Berman, R.F. Adenosine Involvement in Postictal Events in Amygdala-Kindled Rats. Epilepsy Res. 1990, 6, 171-179.
98. Zhang, G.; Franklin, P.H.; Murray, T.F. Activation of Adenosine Receptors Suppresses Behavioral Seizures induced by Kainic Acid in the Rat Prepiriform Cortex. Proc. West Pharmacol. Soc. 1989 32, 149.
99. Janusz, C.A.; Berman, R.F. Adenosinergic Modulation of the EEG and Locomotor Effects of the A2 Agonist, CGS 21680. Pharmacol. Biochem. Behav. 1993, 45, 913-919.
100. Von Lubitz, D.K.; Carter, M.F.; Deutsch, S.I.; Lin, R.C.; Mastropaolo, J.; Meshulam, Y.; Jacobson, K.A. The Effects of Adenosine A3 Receptor Stimulation on Seizures in Mice. Eur. J. Pharmacol. 1995, 275, 23-29.
101. Alasvand Zarasvand, M.; Mirnajafi-Zadeh, J.; Fathollahi, Y,; Palizvan, M.R. Anticonvulsant effect of Bilateral Injection of N6-Cyclohexyladenosine into the CA1 Region of the Hippocampus in Amygdala-Kindled Rats. Epilepsy. Res. 2001, 47, 141-149.
102. Huber, A.; Guttinger, M.; Mohler, H.; Boison, D. Seizure Suppression by Adenosine A(2A) Receptor Activation in a Rat Model of Audiogenic Brainstem Epilepsy. Neurosci. Lett. 2002, 329 289-292.
103. Barraco, R.A.; Swanson, T.H.; Phillis, J.W.; Berman, R.F. Anticonvulsant Effects of Adenosine Analogues on Amygdaloid-Kindled Seizures in Rats. Neurosci. Lett. 1984, 46, 317-322.
104. Rosen, J.B.; Berman, R.F. Differential Effects of Adenosine Analogs on Amygdala, Hippocampus, and Caudate Nucleus Kindled Seizures. Epilepsia 1987, 28, 658-666.
105. Gouder, N.; Fritschy, J.M.; Boison, D. Seizure Suppression by Adenosine A1 Receptor Activation in a Mouse Model of Pharmacoresistant Epilepsy. Epilepsia 2003, 44, 877-885.
106. Assi, A.A. N6-Cyclohexyladenosine and 3-(2-Carboxypiperazine-4-yl)-1-Propenyl-1-Phosphonic Acid Enhance the Effect of Antiepileptic Drugs Against Induced Seizures in Mice. J. Pharm. Pharm. Sci. 2001, 4, 42-51.
107. Janusz, C.A.; Berman, R.F. The Adenosine Binding Enhancer, PD 81,723, Inhibits Epileptiform Bursting in the Hippocampal Brain Slice. Brain Res. 1993, 619, 131-136.
108. Ross, F.M.; Brodie, M.J.; Stone, T.W. Modulation by Adenine Nucleotides of Epileptiform Activity in the CA3 Region of Rat Hippocampal Slices. Br. J. Pharmacol. 1998, 123, 71-80.
109. Kostopoulos, G.; Drapeau. C.; Avoli, M.; Olivier, A.; Villemeure, J.G. Endogenous Adenosine can Reduce Epileptiform Activity in the Human Epileptogenic Cortex Maintained in Vitro. Neurosci. Lett. 1989, 106, 119-124.
110. Albertson, T.E.; Stark, L.G.; Joy, R.M.; Bowyer, J.F. Aminophylline and Kindled Seizures. Exp. Neurol. 1983, 81 703-713.
111. Ault, B.; Olney, M.A.; Joyner, J.L.; Boyer, C.E.; Notrica, M.A.; Soroko, F.E.; Wang, C.M. Pro-Convulsant Actions of Theophylline and Caffeine in the Hippocampus: Implications for the Management of Temporal Lobe Epilepsy. Brain. Res. 1987, 426, 93-102.
112. Richards, W.; Church, JA.; Brent, D.K.; Theophylline-Associated Seizures in Children. Ann. Allergy 1985 54, 276-279.
113. Young, D.; Dragunow, M. Status Epilepticus may be Caused by Loss of Adenosine Anticonvulsant Mechanisms. Neuroscience 1994 58, 245-261.
114. Clifford, D.B.; Olney, JW.; Maniotis, A.; Collins, R.C.; Zorumski, C.F. The Functional Anatomy and Pathology of Lithium-Pilocarpine and High-Dose Pilocarpine Seizures. Neuroscience 1987, 23, 953-968.
115. Huang, L.T.; Yang, S.N.; Liou, C.W.; Hung, P.L.; Lai, M.C.; Wang, C.L.; Wang, T.J. Pentylenetetrazol-Induced Recurrent Seizures in Rat Pups: Time Course on Spatial Learning and Long-Term Effects. Epilepsia 2002, 43, 567-573.
116. Dunwiddie, T.V. Adenosine and Suppression of Seizures. Adv. Neurol. 1999, 79, 1001-1010.
117. Huber, A.; Padrun, V.; Deglon, N.; Aebischer, P.; Mohler, H.; Boison, D. Grafts of Adenosine-Releasing Cells Suppress Seizures in Kindling Epilepsy. Proc. Natl. Acad. Sci. USA 2001, 98 7611-7616.
118. Boison, D.; Huber, A.; Padrun, V.; Deglon, N.; Aebischer, P.; Mohler, H. Seizure Suppression by Adenosine-Releasing Cells is Independent of Seizure Frequency. Epilepsia 2002, 43, 788-796.
119. Zhang, G.; Franklin, P.H.; Murray, T.F. Manipulation of Endogenous Adenosine in the Rat Prepiriform Cortex Modulates Seizure Susceptibility. J. Pharmacol. Exp. Ther. 1993, 264, 1415-1424.
120. Gouder, N.; Scheurer, L.; Fritschy, J-M.; Boison, D. Overexpression of Adenosine Kinase in Epileptic Hippocampus Contributes to Epileptogenesis. J. Neurosci. 2004, 24, 692-701.
121. Erion, M.D.; Wiesner, J.B.; Rosengren, S.; Ugarkar, B.; Boyer, S.H.; Tsuchiya, M.; Nakane, M.; Pettersen, B.A.; Nagahisa, A. Therapeutic Potential of Adenosine Kinase Inhibitors as Analgesic Agents. Drug. Dev. Res. 2000, 50, S14-06.
122. Berman, R.F.; Cortese, B.; Wiesner, J.B. Anticonvulsant Activity of an Adenosine Kinase Inhibitor, GP3269, Against Amygdala-Kindled Seizures in Rats. Soc. Neuroscience Abstracts, 1997
123. Racine, R.J. Modification of Seizure Activity by Electrical Stimulation. II. Motor Seizure. Electroencephalogr. Clin. Neurophysiol. 1972, 32, 281-294.
124. McGaraughty, S.; Chu, K.; Wismer, C. T.; Mikusa, J.; Zhu, C. Z.; Cowart, M.; Kowaluk, E. A.; Jarvis, M. F. Effects of A-134974, a Novel ADO Kinase Inhibitor, on Carrageenan-Induced Inflammatory Hyperalgesia and Locomotor Activity in Rats: Evaluation of the Sites of Action. J Pharmacol. Exp. Ther. 2001, 296, 501-509.
125. Zhu, C. Z.; Mikusa, J.; Chu, K. L.; Cowart, M.; Kowaluk, E. A.; Jarvis, M. F. A-134974: a Novel ADO Kinase Inhibitor, Relieves Tactile Allodynia via Spinal Sites of Action in Peripheral Nerve Injured Rats. Brain Res. 2001, 905, 104-110.
126. Woolf, C.J.; Salter, M.W. Neuronal Plasticity: Increasing the Gain in Pain. Science 2000, 288, 1765-1769.
127. Sawynok, J.; Liu, X.J. ADO in the Spinal Cord and Periphery: Release and Regulation of Pain. Prog. Neurobiol. 2003, 69, 313-340.
128. Keil, G.J.; DeLander, G.E. ADO Kinase and ADO Deaminase Inhibition Modulate Spinal ADO- and Opioid Agonist-Induced Antinociception in Mice. Eur. J. Pharmacol. 1994, 271, 37-46.
129. Poon, A.; Sawynok, J. Antinociception by ADO Analogs and an ADO Kinase Inhibitor: Dependence on Formalin Concentration. Eur. J. Pharmacol. 1995, 286, 177-184.
130. Poon, A.; Sawynok, J. Antinociception by ADO Analogs and Inhibitors of ADO Metabolism in an Inflammatory Thermal Hyperalgesia Model in the Rat. Pain 1998, 74, 235-245.
131. Cottam, H.B.; Wasson, D.B.; Shih, H.C.; Raychaudhuri, A.; Dipasquale, G.; Carson, D.A. New ADO Kinase Inhibitors with Oral Antiflammatory Activity: Synthesis and Biological Evaluation. J. Med. Chem. 1993, 36, 3424-3430.
132. Shryock, J.C.; Belardinelli, L. ADO and ADO Receptors in the Cardiovascular System: Biochemistry, Physiology, and Pharmacology. Am. J. Cardiol. 1997, 79, 2-10.
133. Spyer, K.M.; Thomas, T. A Role for ADO in Modulating Cardio-Respiratory Responses: a Mini-Review. Brain Res. Bull. 2000, 53, 121-124.
134. Scislo, T,J.; Kitchen, A.M.; Augustyniak, R.A.; O'Leary, D.S. Differential Patterns of Sympathetic Responses to Selective Stimulation of Nucleus Tractus Solitarius Purinergic Receptor Subtypes. Clin. Exp. Pharmacol. Physiol. 2001, 28, 120-124.
135. Bonizzoni, E.; Milani, S.; Ongini, E.; Casati, C.; Monopoli, A. Modeling Hemodynamic Profiles by Telemetry in the Rat. A Study with A1 and A2a ADO Agonists. Hypertension 1995, 25, 564-569.
136. Schindler, C.W.; Karcz-Kubicha, M.; Thorndike, E.B.; Muller, C.E.; Tella, S.R.; Goldberg, S.R.; Ferre, S. Lack of ADO A1 and Dopamine D2 Receptor-Mediated Modulation of the Cardiovascular Effects of the ADO A2A Receptor Agonist CGS 21680. Eur. J. Pharmacol. 2004, 484, 269-275.
137. Van Der Graaf, P.H.; Van Schaick, E.A.; Mathot, R.A.; Ijzerman, A.P.; Danhof, M. Mechanism-Based Pharmacokinetic-Pharmacodynamic Modeling of the Effects of N6-CyclopentylADO Analogs on Heart Rate in Rat: Estimation of in vivo Operational Affinity and Efficacy at ADO A1 Receptors. J. Pharmacol. Exp. Ther. 1997, 283, 809-816.
138. Holmgren, M.; Hedner, J.; Mellstrand, T.; Nordberg, G.; Hedner, T. Characterization of the Antinociceptive Effects of Some ADO Analogues in the Rat. Naunyn. Schmiedeberg's Arch. Pharmacol. 1986, 334, 290-293.
139. Suzuki, R.; Stanfa, LC.; Kowaluk, E.A.; Williams, M.; Jarvis, M.F.; Dickenson, A.H. The Effect of ABT-702, a Novel ADO Kinase Inhibitor, on the Responses of Spinal Neurones Following Carrageenan Inflammation and Peripheral Nerve Injury. Br. J. Pharmacol. 2001 132, 1615-1623.
140. Lee, Y.W.; Yaksh, T.L. Pharmacology of the Spinal ADO Receptor which Mediates the Antiallodynic Action of Intrathecal ADO Agonists. J. Pharmacol. Exp. Ther. 1996, 277, 1642-1648.
141. Khandwala, H.; Zhang, Z.; Loomis, C.W. Inhibition of Strychnine-Allodynia is Mediated by Spinal ADO A1- but not A2-Receptors in the Rat. Brain Res. 1998, 808, 106-109.
142. Keil, G.J.; Delander, G.E. Spinally Mediated Antinociception is Induced in Mice by an ADO Kinase, but not an ADO Deaminase Inhibitor. Life Sci. 1992, 51, 171-176.
143. Kowaluk, E.A.; Bhagwat, S.S.; Jarvis, M.F. ADO Kinase Inhibitors. Curr. Pharmaceut. Des. 1998, 4, 403-416.
144. Doak, G.J.; Sawynok, J. Complex Role of Peripheral ADO in the Genesis of the Response to Subcutaneous Formalin in the Rat. Eur. J. Pharmacol. 1995, 281, 311-318.
145. Choca, J.I.; Green, R.D.; Proudfit, H.K. ADO A1 and A2 Receptors of the Substantia Gelatinosa are Located Predominately on Intrinsic Neurons: An Autoradiograph Study. J Pharmacol. Exp. Ther. 1998, 247, 757-764.